Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.0150 (-1.56%) ($11.0150 - $11.0150) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.04% (three month average) | RSI | 55 | Latest Price | $11.0150(-1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 5.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(38%) IWC(37%) IWM(37%) | Factors Impacting BCRX price | BCRX will decline at least -3.52% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-8%) IGOV(-6%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.52% (StdDev 7.04%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $11(0.14%) | 10 Day Moving Average | $10.39(6.02%) | 20 Day Moving Average | $10.08(9.28%) | To recent high | -7.4% | To recent low | 118.8% | Market Cap | $1.943b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |